CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 53 filers reported holding CYTOSORBENTS CORP in Q3 2023. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ROYAL BANK OF CANADA | 7,529 | $14,000 | 0.00% |
| Allworth Financial LP | 37 | $70 | 0.00% |
| VANGUARD GROUP INC | 1,949,551 | $3,665,156 | 0.00% |
| UBS Group AG | 197 | $370 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 3 | $6 | 0.00% |
| SEI INVESTMENTS CO | 13,835 | $26,040 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 79,458 | $149,325 | 0.00% |
| US BANCORP \DE\ | 10,000 | $18,800 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 67,914 | $127,678 | 0.00% |
| WELLS FARGO & COMPANY/MN | 525 | $987 | 0.00% |
| NORTHERN TRUST CORP | 75,015 | $141,028 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 364,920 | $686,234 | 0.00% |
| STATE STREET CORP | 151,093 | $284,055 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 165,059 | $310,311 | 0.00% |
External links
This page lists CYTOSORBENTS CORP's shareholders in Q3 2023. To view CYTOSORBENTS CORP's shareholder history, click here.